Asaf Danziger served as Novocure’s Chief Executive Officer from 2002 to 2024 and has been a director of Novocure since 2012.  From 1998 to 2002, Mr. Danziger was CEO of Cybro Medical, a subsidiary of Imagyn Medical Technologies, Inc., a medical products company. Mr. Danziger holds a B.Sc. in material engineering from Ben Gurion University of the Negev, Israel.